These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 20081810

  • 1. CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival.
    Krasinskas AM, Bartlett DL, Cieply K, Dacic S.
    Mod Pathol; 2010 Apr; 23(4):531-8. PubMed ID: 20081810
    [Abstract] [Full Text] [Related]

  • 2. Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma.
    Brich S, Bozzi F, Perrone F, Tamborini E, Cabras AD, Deraco M, Stacchiotti S, Dagrada GP, Pilotti S.
    Mod Pathol; 2020 Feb; 33(2):217-227. PubMed ID: 31570769
    [Abstract] [Full Text] [Related]

  • 3. Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.
    Illei PB, Rusch VW, Zakowski MF, Ladanyi M.
    Clin Cancer Res; 2003 Jun; 9(6):2108-13. PubMed ID: 12796375
    [Abstract] [Full Text] [Related]

  • 4. The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.
    Singhi AD, Krasinskas AM, Choudry HA, Bartlett DL, Pingpank JF, Zeh HJ, Luvison A, Fuhrer K, Bahary N, Seethala RR, Dacic S.
    Mod Pathol; 2016 Jan; 29(1):14-24. PubMed ID: 26493618
    [Abstract] [Full Text] [Related]

  • 5. Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma.
    Chapel DB, Dubuc AM, Hornick JL, Sholl LM.
    Histopathology; 2021 Jun; 78(7):1032-1042. PubMed ID: 33387364
    [Abstract] [Full Text] [Related]

  • 6. A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas.
    Brcic L, Le Stang N, Gallob F, Pissaloux D, Sequeiros R, Paindavoine S, Pairon JC, Karanian M, Dacic S, Girard N, Churg A, Tirode F, Galateau-Salle F.
    Arch Pathol Lab Med; 2023 Mar 01; 147(3):313-322. PubMed ID: 35738002
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Concordance between CDKN2A homozygous deletion and MTAP immunohistochemical loss in fluoroedenite-induced pleural mesothelioma: An immunohistochemical and molecular study on a single-institution series.
    Broggi G, Massimino M, Failla M, Filetti V, Rapisarda V, Ledda C, Lombardo C, Loreto C, Vigneri P, Caltabiano R.
    Pathol Res Pract; 2024 Jul 01; 259():155350. PubMed ID: 38781764
    [Abstract] [Full Text] [Related]

  • 9. The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature.
    Hassan A, Prabhakaran S, Pulford E, Hocking AJ, Godbolt D, Ziad F, Pandita A, Wessels A, Hussey M, Russell PA, Klebe S.
    Pathology; 2024 Aug 01; 56(5):662-670. PubMed ID: 38789301
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Methylthioadenosine phosphorylase and p16 as surrogate diagnostic markers for CDKN2A homozygous deletion in brain tumors].
    Wang SN, Wang W, Zhang XW, Zhang YQ, Xiong YL, Liu L, Teng LH.
    Zhonghua Bing Li Xue Za Zhi; 2024 May 08; 53(5):439-445. PubMed ID: 38678323
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 08; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

  • 16. Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma.
    Febres-Aldana CA, Chang JC, Jungbluth AA, Adusumilli PS, Bodd FM, Frosina D, Geronimo JA, Hernandez E, Irawan H, Offin MD, Rekhtman N, Travis WD, Vanderbilt C, Zauderer MG, Zhang Y, Ladanyi M, Yang SR, Sauter JL.
    Mod Pathol; 2024 Mar 08; 37(3):100420. PubMed ID: 38185249
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Implications of P16/CDKN2A deletion in pleural mesotheliomas.
    Ladanyi M.
    Lung Cancer; 2005 Jul 08; 49 Suppl 1():S95-8. PubMed ID: 15950811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.